标题
Engineering interferons and interleukins for cancer immunotherapy
作者
关键词
Cytokines, Cytokine engineering, Cell therapy, Drug delivery, Protein engineering, Immune signaling, Ligand-receptor interaction
出版物
ADVANCED DRUG DELIVERY REVIEWS
Volume 182, Issue -, Pages 114112
出版商
Elsevier BV
发表日期
2022-01-24
DOI
10.1016/j.addr.2022.114112
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor
- (2021) Yuying Liu et al. NATURE IMMUNOLOGY
- IL-12 Family Cytokines in Cancer and Immunotherapy
- (2021) Bhalchandra Mirlekar et al. Cancers
- Structural basis for IL-12 and IL-23 receptor sharing reveals a gateway for shaping actions on T versus NK cells
- (2021) Caleb R. Glassman et al. CELL
- Genetic engineering of T cells for immunotherapy
- (2021) Gavin I. Ellis et al. NATURE REVIEWS GENETICS
- Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches
- (2021) Hwai Wen Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting IL-21 to tumor-reactive T cells enhances memory T cell responses and anti-PD-1 antibody therapy
- (2021) Ying Li et al. Nature Communications
- DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
- (2021) Roland Beckmann et al. Nature Communications
- A chimeric GM-CSF/IL18 receptor to sustain CAR T-cell function
- (2021) Shannon Lange et al. Cancer Discovery
- Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
- (2021) Jordan J Feld et al. Lancet Respiratory Medicine
- Heterodimeric IL-15 in Cancer Immunotherapy
- (2021) Cristina Bergamaschi et al. Cancers
- Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma
- (2021) Jennifer A. Foltz et al. CLINICAL CANCER RESEARCH
- The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design
- (2021) Robert A. Saxton et al. IMMUNITY
- Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance
- (2021) Toshihito Hirai et al. JOURNAL OF CLINICAL INVESTIGATION
- Linkage of Lambda Interferons in Protection Against Severe COVID-19
- (2021) Mehdi Shahbazi et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interferon lambda in inflammation and autoimmune rheumatic diseases
- (2021) Rishi R. Goel et al. Nature Reviews Rheumatology
- Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
- (2021) Robert A. Saxton et al. SCIENCE
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
- (2021) Prasanna Jagannathan et al. Nature Communications
- A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy
- (2021) Eric J. Hsu et al. Nature Communications
- A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells
- (2021) Katherine E. Harris et al. Scientific Reports
- Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity
- (2021) Aner Ottolenghi et al. Scientific Reports
- Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist
- (2021) Caleb R Glassman et al. eLife
- NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
- (2021) Takahiro Miyazaki et al. Journal for ImmunoTherapy of Cancer
- Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells
- (2021) Kavya Rakhra et al. Science Immunology
- Selective Janus kinase inhibition preserves interferon-λ–mediated antiviral responses
- (2021) Daniel Schnepf et al. Science Immunology
- Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
- (2021) Jingya Guo et al. CELL RESEARCH
- Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma
- (2021) Adi Diab et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I study of BJ-001, a tumor-targeting interleukin-15 fusion protein, in patients with solid tumor.
- (2021) Ki Y. Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I dose escalation of KD033, a PDL1-IL15 bispecific molecule, in advanced solid tumors.
- (2021) Jason J. Luke et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-selective activity of XTX202, a protein-engineered IL-2, in mice without peripheral toxicities in nonhuman primates.
- (2021) Jennifer O'Neil et al. JOURNAL OF CLINICAL ONCOLOGY
- SENTI-101, a Preparation of Mesenchymal Stromal Cells Engineered to Express IL12 and IL21, Induces Localized and Durable Antitumor Immunity in Preclinical Models of Peritoneal Solid Tumors
- (2021) Alba Gonzalez-Junca et al. MOLECULAR CANCER THERAPEUTICS
- An engineered IL-2 partial agonist promotes CD8+ T cell stemness
- (2021) Fei Mo et al. NATURE
- Local delivery of mRNA-encoding cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models
- (2021) Christian Hotz et al. Science Translational Medicine
- An engineered IL-2 reprogrammed for anti-tumor therapy using a semi-synthetic organism
- (2021) Jerod L. Ptacin et al. Nature Communications
- An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
- (2021) Yuanming Xu et al. Cancer Immunology Research
- Engineered Cytokine Signaling to Improve CAR T Cell Effector Function
- (2021) Matthew Bell et al. Frontiers in Immunology
- Switchable immune modulator for tumor-specific activation of anticancer immunity
- (2021) Yu Zhao et al. Science Advances
- A HER2 Tri-Specific NK Cell Engager Mediates Efficient Targeting of Human Ovarian Cancer
- (2021) Daniel A. Vallera et al. Cancers
- To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
- (2021) Da Shi et al. ADVANCED DRUG DELIVERY REVIEWS
- De novo developed protein binders mimicking Interferon lambda signaling
- (2021) Lucie Kolářová et al. FEBS Journal
- An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
- (2021) Hongchuan Liu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma
- (2021) Paul-Joseph Aspuria et al. Science Translational Medicine
- A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
- (2021) Qian Zhang et al. Science Translational Medicine
- Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
- (2021) Xuezhi Cao et al. Nature Communications
- 718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models
- (2021) Christopher Nirschl et al. Journal for ImmunoTherapy of Cancer
- Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
- (2021) Kevin Conlon et al. Journal for ImmunoTherapy of Cancer
- 444 GTB-3550 tri-specific killer engager TriKE™ drives NK cells expansion and cytotoxicity in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) patients
- (2021) Martin Felices et al. Journal for ImmunoTherapy of Cancer
- 719 XTX301, a protein-engineered IL-12, exhibits tumor-selective activity in mice without peripheral toxicities and is well tolerated in non-human primates
- (2021) Ekta Patel et al. Journal for ImmunoTherapy of Cancer
- 713 Novel protease activatable linker with tumor targeting motifs enhances the retention of cytokine prodrug and active cytokine at disease site and demonstrates improved efficacy in preclinical model
- (2021) Emma Langley et al. Journal for ImmunoTherapy of Cancer
- 706 Conditional cytokine therapeutics for tumor-selective biological activity: preclinical characterization of a dual-masked IFN-a2b
- (2021) Alexey Berezhnoy et al. Journal for ImmunoTherapy of Cancer
- 723 WTX-613, a conditionally activated IFNα INDUKINE™ molecule, induces anti-tumor immune responses resulting in strong tumor growth control in syngeneic mouse tumor models
- (2021) Ethika Tyagi et al. Journal for ImmunoTherapy of Cancer
- 509 A first-in-human phase 1 study of NL-201 in patients with relapsed or refractory cancer
- (2021) Aung Naing et al. Journal for ImmunoTherapy of Cancer
- 711 IGM-7354 is an anti-PD-L1 IgM antibody and IL-15 cytokine fusion that enhances NK and CD8+ T cell proliferation and tumor cytotoxicity plus potently reverses T cell exhaustion
- (2021) Thierry Giffon et al. Journal for ImmunoTherapy of Cancer
- 717 Selective activation of CD8+ T cells by a CD8-targeted IL-2 results in enhanced anti-tumor efficacy and safety
- (2021) Kelly Moynihan et al. Journal for ImmunoTherapy of Cancer
- 578 CD8-targeted IL-2 drives potent anti-tumor efficacy and promotes action of tumor specific vaccines
- (2021) Hussein Sultan et al. Journal for ImmunoTherapy of Cancer
- Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells
- (2021) Bo Zhang et al. Nature Biomedical Engineering
- CUE-101, a Novel HPV16 E7-pHLA-IL-2-Fc Fusion Protein, Enhances Tumor Antigen Specific T Cell Activation for the Treatment of HPV16-Driven Malignancies
- (2020) Steven N Quayle et al. CLINICAL CANCER RESEARCH
- Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
- (2020) Leander Huyghe et al. EMBO Molecular Medicine
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- B cells and tertiary lymphoid structures promote immunotherapy response
- (2020) Beth A. Helmink et al. NATURE
- Interleukin-23 engineering improves CAR T cell function in solid tumors
- (2020) Xingcong Ma et al. NATURE BIOTECHNOLOGY
- Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist
- (2020) Giulia Parisi et al. Nature Communications
- Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma
- (2020) Alain P. Algazi et al. CLINICAL CANCER RESEARCH
- Developmental Relationships of Four Exhausted CD8+ T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms
- (2020) Jean-Christophe Beltra et al. IMMUNITY
- Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)
- (2020) Adi Diab et al. Cancer Discovery
- Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
- (2020) Deanna M. Santer et al. PLoS Pathogens
- Engineered IL-21 Cytokine Muteins Fused to Anti-PD-1 Antibodies Can Improve CD8+ T Cell Function and Anti-tumor Immunity
- (2020) Shanling Shen et al. Frontiers in Immunology
- Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
- (2020) Karin M Knudson et al. Journal for ImmunoTherapy of Cancer
- ALKS 4230: a novel engineered IL-2 fusion protein with an improved cellular selectivity profile for cancer immunotherapy
- (2020) Jared E Lopes et al. Journal for ImmunoTherapy of Cancer
- NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer
- (2020) Joshua M Walker et al. Journal for ImmunoTherapy of Cancer
- Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours
- (2020) Aslan Mansurov et al. Nature Biomedical Engineering
- IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
- (2020) Margaux Hubert et al. Science Immunology
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design
- (2020) Nikhil I Khushalani et al. Future Oncology
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Type III interferons disrupt the lung epithelial barrier upon viral recognition
- (2020) Achille Broggi et al. SCIENCE
- Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
- (2020) Aazam Ghelani et al. Frontiers in Immunology
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- (2020) Catherine S. Grasso et al. CANCER CELL
- A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells
- (2020) Upasana Sunil Arvindam et al. LEUKEMIA
- Engineered IL-10 variants elicit potent immunomodulatory effects at low ligand doses
- (2020) Claire Gorby et al. Science Signaling
- Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
- (2020) Anusha Kalbasi et al. Science Translational Medicine
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- NK-Cell-Mediated Targeting of Various Solid Tumors Using a B7-H3 Tri-Specific Killer Engager In Vitro and In Vivo
- (2020) Daniel A. Vallera et al. Cancers
- An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
- (2020) Liliane Khoryati et al. Science Immunology
- An IL-2-grafted antibody immunotherapy with potent efficacy against metastatic cancer
- (2020) Dilara Sahin et al. Nature Communications
- Exploitation of Elevated Extracellular ATP to Specifically Direct Antibody to Tumor Microenvironment
- (2020) Futa Mimoto et al. Cell Reports
- Engineering IL-2 to Give New Life to T Cell Immunotherapy
- (2020) Willem W. Overwijk et al. Annual Review of Medicine
- Fine-Tuning Cytokine Signals
- (2019) Jian-Xin Lin et al. Annual Review of Immunology
- De novo design of potent and selective mimics of IL-2 and IL-15
- (2019) Daniel-Adriano Silva et al. NATURE
- Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
- (2019) Dario Neri Cancer Immunology Research
- Interferons α and β in cancer: therapeutic opportunities from new insights
- (2019) Ernest C. Borden NATURE REVIEWS DRUG DISCOVERY
- Structure of the IFNγ receptor complex guides design of biased agonists
- (2019) Juan L. Mendoza et al. NATURE
- Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9
- (2019) Denise Skrombolas et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes
- (2019) Nazanin Rohani et al. CANCER RESEARCH
- Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
- (2019) Linh T. Nguyen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Causes, consequences, and therapy of tumors acidosis
- (2019) Smitha R. Pillai et al. CANCER AND METASTASIS REVIEWS
- Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model
- (2019) Meiqi Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
- (2019) Warren J. Leonard et al. IMMUNITY
- Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
- (2019) Alberto Mantovani et al. IMMUNITY
- Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
- (2019) Kritika Mohan et al. SCIENCE
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors
- (2019) Salah-Eddine Bentebibel et al. Cancer Discovery
- Enzyme-Activatable Interferon–Poly(α-amino acid) Conjugates for Tumor Microenvironment Potentiation
- (2019) Hao Wang et al. BIOMACROMOLECULES
- Antibody-based delivery of cytokine payloads to carbonic anhydrase IX leads to cancer cures in immunocompetent tumor-bearing mice
- (2019) Barbara Ziffels et al. MOLECULAR CANCER THERAPEUTICS
- Supercharging adoptive T cell therapy to overcome solid tumor–induced immunosuppression
- (2019) Sherly Mardiana et al. Science Translational Medicine
- Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy
- (2019) Noor Momin et al. Science Translational Medicine
- Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial
- (2019) Shihong Zhang et al. Cancer Immunology Research
- Thermoresponsive and Protease‐Cleavable Interferon‐Polypeptide Conjugates with Spatiotemporally Programmed Two‐Step Release Kinetics for Tumor Therapy
- (2019) Zhuoran Wang et al. Advanced Science
- Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
- (2019) Qingnan Zhao et al. Journal for ImmunoTherapy of Cancer
- Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
- (2019) Kari M. Morrissey et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
- (2019) Joseph L. Benci et al. CELL
- Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
- (2019) E. Antonio Chiocca et al. Science Translational Medicine
- 1223PGI101, a novel triple-targeting bispecific CD80-IgG4-IL2variant fusion protein, elicits synergistic anti-tumour effects in preclinical models
- (2019) J C Park et al. ANNALS OF ONCOLOGY
- Bempegaldesleukin (NKTR-214): a CD-122-biased IL-2 receptor agonist for cancer immunotherapy
- (2019) Stephen K. Doberstein EXPERT OPINION ON BIOLOGICAL THERAPY
- A strategy for the selection of monovalent antibodies that span protein dimer interfaces
- (2019) Jamie B. Spangler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-15Rα membrane-anchorage either in cis or in trans is required for stabilization of IL-15 and optimal signaling
- (2019) Agnès Quéméner et al. JOURNAL OF CELL SCIENCE
- Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment
- (2019) Bradley N. Mills et al. Cell Reports
- Kinetics of cytokine receptor trafficking determine signaling and functional selectivity
- (2019) Jonathan Martinez-Fabregas et al. eLife
- Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
- (2019) Thomas A. Waldmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Trans-endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
- (2019) Olga M. Anton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A comprehensive pathway map of IL-18-mediated signalling
- (2019) D.A.B Rex et al. Journal of Cell Communication and Signaling
- Pembrolizumab Plus Pegylated Interferon alfa-2b or Ipilimumab for Advanced Melanoma or Renal Cell Carcinoma: Dose-Finding Results from the Phase Ib KEYNOTE-029 Study
- (2018) Michael B. Atkins et al. CLINICAL CANCER RESEARCH
- Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques
- (2018) Cristina Bergamaschi et al. CYTOKINE
- Chemotherapeutic drug delivery by tumoral extracellular matrix targeting
- (2018) René Raavé et al. JOURNAL OF CONTROLLED RELEASE
- A Dose-escalation Study of Recombinant Human Interleukin-18 in Combination With Ofatumumab After Autologous Peripheral Blood Stem Cell Transplantation for Lymphoma
- (2018) Michael J. Robertson et al. JOURNAL OF IMMUNOTHERAPY
- IL-2 and Beyond in Cancer Immunotherapy
- (2018) John M. Wrangle et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
- (2018) Jonathan T. Sockolosky et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- A hierarchy of affinities between cytokine receptors and the common gamma chain leads to pathway cross-talk
- (2018) Pauline Gonnord et al. Science Signaling
- A hierarchy of affinities between cytokine receptors and the common gamma chain leads to pathway cross-talk
- (2018) Pauline Gonnord et al. Science Signaling
- Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
- (2018) Flávia Castro et al. Frontiers in Immunology
- The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses
- (2018) Nicolle H. Rekers et al. OncoImmunology
- Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
- (2018) Keunok Jung et al. OncoImmunology
- CD19 CAR T Cells Expressing IL-12 Eradicate Lymphoma in Fully Lymphoreplete Mice through Induction of Host Immunity
- (2018) Gray Kueberuwa et al. Molecular Therapy-Oncolytics
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients
- (2018) Ida Netterberg et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Mechanisms of signalling and biased agonism in G protein-coupled receptors
- (2018) Denise Wootten et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mapping Determinants of Cytokine Signaling via Protein Engineering
- (2018) Claire Gorby et al. Frontiers in Immunology
- 412PDClinical activity, safety, and PK/PD from a phase I study of RO6874281, a fibroblast activation protein (FAP) targeted interleukin-2 variant (IL-2v)
- (2018) I Melero et al. ANNALS OF ONCOLOGY
- Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy
- (2018) Anandaroop Mukhopadhyay et al. GENE THERAPY
- Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12
- (2018) Christopher S. Garris et al. IMMUNITY
- A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
- (2018) Laurence B. Peterson et al. JOURNAL OF AUTOIMMUNITY
- Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
- (2018) Diwakar Davar et al. JOURNAL OF CLINICAL ONCOLOGY
- The Interferon-Gamma Paradox in Cancer
- (2018) M. Raza Zaidi JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
- (2018) Yong Liang et al. Nature Communications
- Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy
- (2018) Lorenzo Mortara et al. Frontiers in Immunology
- The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex
- (2018) Caroline Jochems et al. OncoImmunology
- Lipid nanoparticles that deliver IL-12 messenger RNA suppress tumorigenesis in MYC oncogene-driven hepatocellular carcinoma
- (2018) Ian Lai et al. Journal for ImmunoTherapy of Cancer
- A novel anti-cancer L19-interleukin-12 fusion protein with an optimized peptide linker efficiently localizes in vivo at the site of tumors
- (2018) Tiziano Ongaro et al. JOURNAL OF BIOTECHNOLOGY
- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
- (2017) Juan L. Mendoza et al. IMMUNITY
- Interleukin-18: Biological properties and role in disease pathogenesis
- (2017) Gilles Kaplanski IMMUNOLOGICAL REVIEWS
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- A comparison of exogenous and endogenous CESTMRI methods for evaluating in vivo pH
- (2017) Leila R. Lindeman et al. MAGNETIC RESONANCE IN MEDICINE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
- (2017) Rodrigo Vazquez-Lombardi et al. Nature Communications
- Enhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody
- (2017) Jonathan K. Fallon et al. Oncotarget
- Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity
- (2017) Jörg U. Schmohl et al. Cancer Research and Treatment
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo
- (2017) Franziska Eckert et al. OncoImmunology
- Proteases in cancer drug delivery
- (2016) Jennifer Vandooren et al. ADVANCED DRUG DELIVERY REVIEWS
- Therapeutic efficacy of an anti-PD-L1 antibody based immunocytokine in a metastatic mouse model of colorectal cancer
- (2016) Xi Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma
- (2016) Ajjai Alva et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+T cells for adoptive immunotherapy of cancer and infections
- (2016) A. N. Hasan et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
- (2016) Sinnie Sin Man Ng et al. CLINICAL CANCER RESEARCH
- NKTR-214, an Engineered Cytokine with Biased IL2 Receptor Binding, Increased Tumor Exposure, and Marked Efficacy in Mouse Tumor Models
- (2016) D. H. Charych et al. CLINICAL CANCER RESEARCH
- Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas
- (2016) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
- (2016) D. A. Vallera et al. CLINICAL CANCER RESEARCH
- Endocytic regulation of cytokine receptor signaling
- (2016) Jaroslaw Cendrowski et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IFN-λ cancer immunotherapy: new kid on the block
- (2016) Ahmed Lasfar et al. Immunotherapy
- IL-15 boosts the function and migration of human terminally differentiated CD8+T cells by inducing a unique gene signature
- (2016) Ruka Setoguchi INTERNATIONAL IMMUNOLOGY
- Biophysical stability of hyFc fusion protein with regards to buffers and various excipients
- (2016) Jun Yeul Lim et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins
- (2016) Dario Venetz et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses
- (2016) Bai Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Review of the recombinant human interferon gamma as an immunotherapeutic: Impacts of production platforms and glycosylation
- (2016) Ali Razaghi et al. JOURNAL OF BIOTECHNOLOGY
- IL-15Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
- (2016) Mélanie Desbois et al. JOURNAL OF IMMUNOLOGY
- Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growth
- (2016) Jing Shen et al. Journal of Translational Medicine
- In Vivo Antitumor Activity of a Recombinant IL7/IL15 Hybrid Cytokine in Mice
- (2016) Y. Song et al. MOLECULAR CANCER THERAPEUTICS
- Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker
- (2016) Joerg U Schmohl et al. MOLECULAR THERAPY
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
- (2016) Richard P. Junghans et al. PROSTATE
- Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2
- (2016) N. Arenas-Ramirez et al. Science Translational Medicine
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
- (2016) Cameron J. Turtle et al. Science Translational Medicine
- IL-21 and T Cell Differentiation: Consider the Context
- (2016) Yuan Tian et al. TRENDS IN IMMUNOLOGY
- Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker
- (2016) Joerg U. Schmohl et al. Oncotarget
- A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C
- (2016) Robert Flisiak et al. PLoS One
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
- (2015) O. Trédan et al. ANNALS OF ONCOLOGY
- Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
- (2015) William R. Strohl BIODRUGS
- Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma
- (2015) S. Bhatt et al. BLOOD
- A targeted IL-15 fusion protein with potent anti-tumor activity
- (2015) Siqi Chen et al. CANCER BIOLOGY & THERAPY
- Synergistic Innate and Adaptive Immune Response to Combination Immunotherapy with Anti-Tumor Antigen Antibodies and Extended Serum Half-Life IL-2
- (2015) Eric F. Zhu et al. CANCER CELL
- Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands
- (2015) Ignacio Moraga et al. CELL
- The IL-15-Based ALT-803 Complex Enhances Fc RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
- (2015) M. Rosario et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Recombinant human heterodimeric IL-15 complex displays extensive and reproducible N- and O-linked glycosylation
- (2015) M. Thaysen-Andersen et al. GLYCOCONJUGATE JOURNAL
- Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms
- (2015) Jamie B. Spangler et al. IMMUNITY
- Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model
- (2015) Dimitrios Mathios et al. INTERNATIONAL JOURNAL OF CANCER
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
- (2015) Paul H. Kierstead et al. JOURNAL OF CONTROLLED RELEASE
- Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature
- (2015) Niklas Börschel et al. LEUKEMIA RESEARCH
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution
- (2015) Alice Tzeng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cells require IL-28R for optimal in vivo activity
- (2015) Fernando Souza-Fonseca-Guimaraes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-2Rα mediates temporal regulation of IL-2 signaling and enhances immunotherapy
- (2015) Ee W. Su et al. Science Translational Medicine
- Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
- (2015) E. Suzanne Cohen et al. Nature Communications
- Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma
- (2015) Xin Li et al. Thoracic Cancer
- The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
- (2015) T. A. Waldmann Cancer Immunology Research
- IL-21: A Pleiotropic Cytokine with Potential Applications in Oncology
- (2015) Michela Croce et al. Journal of Immunology Research
- Soluble Interleukin-15 Complexes Are Generated In Vivo by Type I Interferon Dependent and Independent Pathways
- (2015) Scott M. Anthony et al. PLoS One
- The immunocytokine NHS-IL12 as a potential cancer therapeutic
- (2015) Jonathan Fallon et al. Oncotarget
- Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
- (2015) Wei Zhang et al. NEOPLASIA
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
- (2014) Francesca Pretto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- IL-15 regulates memory CD8+ T cell O-glycan synthesis and affects trafficking
- (2014) Jeffrey C. Nolz et al. JOURNAL OF CLINICAL INVESTIGATION
- A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
- (2014) Andrew J. Muir et al. JOURNAL OF HEPATOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- PEGylation Improves the Pharmacokinetic Properties and Ability of Interferon Gamma to Inhibit Growth of a Human Tumor Xenograft in Athymic Mice
- (2014) Christine M. Fam et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Interleukin-21: a double-edged sword with therapeutic potential
- (2014) Rosanne Spolski et al. NATURE REVIEWS DRUG DISCOVERY
- TG1042 (Adenovirus-interferon-γ) in Primary Cutaneous B-cell Lymphomas: A Phase II Clinical Trial
- (2014) Brigitte Dreno et al. PLoS One
- Intravesical ALT-803 and BCG Treatment Reduces Tumor Burden in a Carcinogen Induced Bladder Cancer Rat Model; a Role for Cytokine Production and NK Cell Expansion
- (2014) Evan Gomes-Giacoia et al. PLoS One
- Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties
- (2014) Kyoung Song et al. PLoS One
- The structural basis for receptor recognition of human interleukin-18
- (2014) Naotaka Tsutsumi et al. Nature Communications
- High efficiency cell-specific targeting of cytokine activity
- (2014) Geneviève Garcin et al. Nature Communications
- The Dose-Dependent Tumor Targeting of Antibody-IFN Fusion Proteins Reveals an Unexpected Receptor-Trapping Mechanism In Vivo
- (2014) T. Hemmerle et al. Cancer Immunology Research
- Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study
- (2014) Shailender Bhatia et al. Journal for ImmunoTherapy of Cancer
- Albumin as a versatile platform for drug half-life extension
- (2013) Darrell Sleep et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- The Cytokines IL-21 and GM-CSF Have Opposing Regulatory Roles in the Apoptosis of Conventional Dendritic Cells
- (2013) Chi-Keung Wan et al. IMMUNITY
- Characterization and Favorablein VivoProperties of Heterodimeric Soluble IL-15·IL-15Rα Cytokine Compared to IL-15 Monomer
- (2013) Elena Chertova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Human IL-2 Mutein with Higher Antitumor Efficacy Than Wild Type IL-2
- (2013) T. Carmenate et al. JOURNAL OF IMMUNOLOGY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 in Combination With Rituximab in Patients With Non-Hodgkin Lymphoma
- (2013) Michael J. Robertson et al. JOURNAL OF IMMUNOTHERAPY
- Crystal Structure of the Interferon Gamma Receptor Alpha Chain from Chicken Reveals an Undetected Extra Helix Compared with the Human Counterparts
- (2013) Zhiguang Ping et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Gene delivery of albumin binding peptide-interferon-gamma fusion protein with improved pharmacokinetic properties and sustained biological activity
- (2013) Noriko Miyakawa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042
- (2013) Nathalie Accart et al. Journal of Translational Medicine
- Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
- (2013) Peter J.K. van Meer et al. mAbs
- Interleukin-21 Enhances Rituximab Activity in a Cynomolgus Monkey Model of B Cell Depletion and in Mouse B Cell Lymphoma Models
- (2013) Cecile M. Krejsa et al. PLoS One
- Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice
- (2013) Heungnam Kim et al. PLoS One
- Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index
- (2013) L. R. Desnoyers et al. Science Translational Medicine
- Nonlytic Fc-fused IL-7 synergizes with Mtb32 DNA vaccine to enhance antigen-specific T cell responses in a therapeutic model of tuberculosis
- (2013) So-Shin Ahn et al. VACCINE
- Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study
- (2013) F. Simpkins et al. Cancer Immunology Research
- Interleukin-18 and IL-18 Binding Protein
- (2013) Charles A. Dinarello et al. Frontiers in Immunology
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis
- (2012) K. Attridge et al. BLOOD
- IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
- (2012) N. Cieri et al. BLOOD
- A Phase I Dose-Finding Trial of Recombinant Interleukin-21 and Rituximab in Relapsed and Refractory Low Grade B-cell Lymphoproliferative Disorders
- (2012) J. M. Timmerman et al. CLINICAL CANCER RESEARCH
- Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma
- (2012) Adil Daud et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Preclinical Safety, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Interleukin-21 in Cynomolgus Macaques (Macaca fascicularis)
- (2012) Kimberly S. Waggie et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- The Immunocytokine L19–IL2 Eradicates Cancer When Used in Combination with CTLA-4 Blockade or with L19-TNF
- (2012) Kathrin Schwager et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ex Vivo Interleukin-12-Priming During CD8+ T Cell Activation Dramatically Improves Adoptive T Cell Transfer Antitumor Efficacy in a Lymphodepleted Host
- (2012) Mark P. Rubinstein et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Selective Targeting of Interferon to Stromal Fibroblasts and Pericytes as a Novel Therapeutic Approach to Inhibit Angiogenesis and Tumor Growth
- (2012) R. Bansal et al. MOLECULAR CANCER THERAPEUTICS
- Exploiting a natural conformational switch to engineer an interleukin-2 ‘superkine’
- (2012) Aron M. Levin et al. NATURE
- Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
- (2012) Aaron M Ring et al. NATURE IMMUNOLOGY
- An Il12-Il2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation Of Nk And T Cells For An Anti-Tumor Attack
- (2012) Tobias Jahn et al. PLoS One
- Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
- (2012) A. G. Chapuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protease-Activated Drug Development
- (2012) Ki Young Choi et al. Theranostics
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood
- (2011) M. C. Sneller et al. BLOOD
- Antitumor activities of recombinant human interferon (IFN)-λ1 in vitro and in xenograft models in vivo for colon cancer
- (2011) Xiwu Hui et al. CANCER LETTERS
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
- (2011) Christoph Thomas et al. CELL
- A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma
- (2011) T. K. Eigentler et al. CLINICAL CANCER RESEARCH
- A Phase 1 Study of AS1409, a Novel Antibody-Cytokine Fusion Protein, in Patients with Malignant Melanoma or Renal Cell Carcinoma
- (2011) S. M. Rudman et al. CLINICAL CANCER RESEARCH
- A Low-Toxicity IL-2-Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity
- (2011) S. D. Gillies et al. CLINICAL CANCER RESEARCH
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
- (2011) Kai-ping Han et al. CYTOKINE
- Binding and activity of all human alpha interferon subtypes
- (2011) Thomas B. Lavoie et al. CYTOKINE
- The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis
- (2011) Catherine E. Steding et al. IMMUNOLOGY
- Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help
- (2011) Magdalena Hagn et al. IMMUNOLOGY AND CELL BIOLOGY
- Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7
- (2011) Nadine Pasche et al. JOURNAL OF BIOTECHNOLOGY
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vivo Administration of the Recombinant IL-7/Hepatocyte Growth Factor Hybrid Cytokine Efficiently Restores Thymopoiesis and Naive T Cell Generation in Lethally Irradiated Mice after Syngeneic Bone Marrow Transplantation
- (2011) J. Jin et al. JOURNAL OF IMMUNOLOGY
- Prolonged Circulation Half-life of Interferon γ Activity by Gene Delivery of Interferon γ–Serum Albumin Fusion Protein in Mice
- (2011) Noriko Miyakawa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
- (2011) Douglas J. Schwartzentruber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates
- (2010) E. Lugli et al. BLOOD
- Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
- (2010) C. Xuan et al. BLOOD
- Antitumor activity of Type I and Type III interferons in BNL hepatoma model
- (2010) Walid Abushahba et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Safety and Clinical Effect of Subcutaneous Human Interleukin-21 in Patients with Metastatic Melanoma or Renal Cell Carcinoma: A Phase I Trial
- (2010) H. Schmidt et al. CLINICAL CANCER RESEARCH
- Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy
- (2010) C. Sportes et al. CLINICAL CANCER RESEARCH
- The tumour-targeting human L19-IL2 immunocytokine: Preclinical safety studies, phase I clinical trial in patients with solid tumours and expansion into patients with advanced renal cell carcinoma
- (2010) Manfred Johannsen et al. EUROPEAN JOURNAL OF CANCER
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
- (2009) Michael S. Sabel et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma
- (2009) Ahmad A. Tarhini et al. CANCER
- Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells
- (2009) Shomyseh Sanjabi et al. IMMUNITY
- A Low Interleukin-2 Receptor Signaling Threshold Supports the Development and Homeostasis of T Regulatory Cells
- (2009) Aixin Yu et al. IMMUNITY
- A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
- (2009) T. S. Bekaii-Saab et al. MOLECULAR CANCER THERAPEUTICS
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
- A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
- (2009) Volker Schellenberger et al. NATURE BIOTECHNOLOGY
- Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2
- (2008) C. Schliemann et al. BLOOD
- Immune activation in advanced cancer patients treated with recombinant IL-21: multianalyte profiling of serum proteins
- (2008) Michael G. Dodds et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
- (2008) M. J. Robertson et al. CLINICAL CANCER RESEARCH
- Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: Results from a prospectively designed analysis of progression-free survival
- (2008) David S. Alberts et al. GYNECOLOGIC ONCOLOGY
- Twelve immunotherapy drugs that could cure cancers
- (2008) Martin A. ‘Mac’ Cheever IMMUNOLOGICAL REVIEWS
- Phase I Study of Recombinant Interleukin-21 in Patients With Metastatic Melanoma and Renal Cell Carcinoma
- (2008) John A. Thompson et al. JOURNAL OF CLINICAL ONCOLOGY
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
- (2008) Claude Sportès et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
- (2008) Alexander MM Eggermont et al. LANCET
- Structural basis for antagonism of human interleukin 18 by poxvirus interleukin 18-binding protein
- (2008) B. Krumm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
- Releasable PEGylation of proteins with customized linkers
- (2007) David Filpula et al. ADVANCED DRUG DELIVERY REVIEWS
- Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity
- (2007) Rosanne Spolski et al. Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now